Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 291

1.

Open letter to the Hon Tony Abbott MP.

McMichael AJ, Leeder SR, Armstrong BK, Basten A, Doherty PC, Douglas RM, Green AC, Nossal GJ, Shearman DJ, Stanley FJ, Vimpani GV, Wodak AD.

Med J Aust. 2014 Sep 1;201(5):252. No abstract available.

PMID:
25163366
2.

Immunology and world health: key contributions from the global community.

Nossal GJ.

Ann N Y Acad Sci. 2013 Apr;1283:1-7. doi: 10.1111/nyas.12035. Epub 2013 Feb 6. Review.

PMID:
23387415
3.

Vaccines of the future.

Nossal GJ.

Vaccine. 2011 Dec 30;29 Suppl 4:D111-5. doi: 10.1016/j.vaccine.2011.06.089. Epub 2011 Dec 18. Review.

PMID:
22185835
4.

Vaccines and future global health needs.

Nossal GJ.

Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2833-40. doi: 10.1098/rstb.2011.0093.

5.

Recent trends in global immunisation.

Nossal GJ.

Adv Exp Med Biol. 2011;697:9-16. doi: 10.1007/978-1-4419-7185-2_2. No abstract available.

PMID:
21120716
6.

Public health. The cholera crisis in Africa.

Bhattacharya S, Black R, Bourgeois L, Clemens J, Cravioto A, Deen JL, Dougan G, Glass R, Grais RF, Greco M, Gust I, Holmgren J, Kariuki S, Lambert PH, Liu MA, Longini I, Nair GB, Norrby R, Nossal GJ, Ogra P, Sansonetti P, von Seidlein L, Songane F, Svennerholm AM, Steele D, Walker R.

Science. 2009 May 15;324(5929):885. doi: 10.1126/science.1173890. No abstract available.

PMID:
19443768
7.

Pillars article: antibody production by single cells. 1958. Nature 181: 1419-1420.

Nossal GJ, Lederberg J.

J Immunol. 2009 Feb 1;182(3):1231-2. No abstract available.

8.

Evidence for the clonal abortion theory of B-lymphocyte tolerance. 1975.

Nossal GJ, Pike BL.

J Immunol. 2007 Nov 1;179(9):5619-32. No abstract available.

9.

One cell-one antibody: prelude and aftermath.

Nossal GJ.

Nat Immunol. 2007 Oct;8(10):1015-7. No abstract available.

PMID:
17878906
10.

Mentors and manipulation.

Nossal GJ.

Nature. 2004 Jun 24;429(6994):811. No abstract available.

PMID:
15215842
11.

A healthier climate for the funding of vaccine research.

Nossal GJ.

Nat Immunol. 2004 May;5(5):457-9.

PMID:
15116107
12.

The double helix and immunology.

Nossal GJ.

Nature. 2003 Jan 23;421(6921):440-4. Review.

PMID:
12540919
13.

Gates, GAVI, the glorious global funds and more: all you ever wanted to know.

Nossal GJ.

Immunol Cell Biol. 2003 Feb;81(1):20-2.

PMID:
12534942
14.

One cell, one antibody: prelude and aftermath.

Nossal GJ.

Immunol Rev. 2002 Jul;185:15-23.

PMID:
12190918
15.

A purgative mastery.

Nossal GJ.

Nature. 2001 Aug 16;412(6848):685-6. Review. No abstract available.

PMID:
11507616
16.

The Global Alliance for Vaccines and Immunization--a millennial challenge.

Nossal GJ.

Nat Immunol. 2000 Jul;1(1):5-8. No abstract available.

PMID:
10881163
17.

The new biology and human reproduction.

Nossal GJ.

Aust N Z J Obstet Gynaecol. 2000 Nov;40(4):373-6. No abstract available.

PMID:
11194419
18.

Modern medicine and global communicable diseases: new partnerships for progress.

Nossal GJ.

Aust N Z J Med. 2000 Apr;30(2):267-71. No abstract available.

PMID:
10833122
19.

Inactivated measles vaccine and the risk of adverse events.

Nossal GJ.

Bull World Health Organ. 2000;78(2):224-5. No abstract available.

20.

Vaccination and autoimmunity.

Nossal GJ.

J Autoimmun. 2000 Feb;14(1):13-5. No abstract available.

PMID:
10648112
21.

Global immunization for the 21st century.

Nossal GJ.

Science. 1999 Apr 23;284(5414):587. No abstract available.

22.

WHO and health research--some personal reflections.

Nossal GJ.

World Health Forum. 1998;19(4):369-76.

PMID:
10050162
23.
24.

Affinity maturation of the primary response by V gene diversification.

Tarlinton DM, Light A, Nossal GJ, Smith KG.

Curr Top Microbiol Immunol. 1998;229:71-83. Review. No abstract available.

PMID:
9479849
25.

Host immunobiology and vaccine development.

Nossal GJ.

Lancet. 1997 Nov 1;350(9087):1316-9.

PMID:
9357421
26.
27.

The Jennerian heritage: new generation vaccines for all the world's children and adults.

Nossal GJ, Lambert PH.

Biologicals. 1997 Jun;25(2):131-5. No abstract available.

PMID:
9236039
28.

B lymphocyte physiology: the beginning and the end.

Nossal GJ.

Ciba Found Symp. 1997;204:220-30; discussion 230-1. Review.

PMID:
9107424
29.

Immunological tolerance in germinal centres.

Pulendran B, van Driel R, Nossal GJ.

Immunol Today. 1997 Jan;18(1):27-32. Review. No abstract available.

PMID:
9018971
30.

The xid mutation diminishes memory B cell generation but does not affect somatic hypermutation and selection.

Ridderstad A, Nossal GJ, Tarlinton DM.

J Immunol. 1996 Oct 15;157(8):3357-65.

PMID:
8871632
31.

Clonal anergy of B cells: a flexible, reversible, and quantitative concept.

Nossal GJ.

J Exp Med. 1996 May 1;183(5):1953-6. Review. No abstract available.

32.

The Walter and Eliza Hall Institute of Medical Research.

Nossal GJ.

Mol Med. 1996 Mar;2(2):165-8. No abstract available.

33.

The phenotype and fate of the antibody-forming cells of the splenic foci.

Smith KG, Hewitson TD, Nossal GJ, Tarlinton DM.

Eur J Immunol. 1996 Feb;26(2):444-8.

PMID:
8617316
34.

FAS is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigen.

Smith KG, Nossal GJ, Tarlinton DM.

Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11628-32.

35.

The Walter and Eliza Hall Institute of Medical Research 1965-1995: from basic research to clinical triumphs.

Nossal GJ.

Med J Aust. 1995 Dec 4-18;163(11-12):599-603. No abstract available.

PMID:
8538553
36.

B1 and B2 cells differ in their potential to switch immunoglobulin isotype.

Tarlinton DM, McLean M, Nossal GJ.

Eur J Immunol. 1995 Dec;25(12):3388-93.

PMID:
8566028
37.
38.

Soluble antigen can cause enhanced apoptosis of germinal-centre B cells.

Pulendran B, Kannourakis G, Nouri S, Smith KG, Nossal GJ.

Nature. 1995 May 25;375(6529):331-4.

PMID:
7753199
39.
40.
41.

Bcl-2 increases memory B cell recruitment but does not perturb selection in germinal centers.

Smith KG, Weiss U, Rajewsky K, Nossal GJ, Tarlinton DM.

Immunity. 1994 Dec;1(9):803-13.

PMID:
7895168
42.

Immunology. How to stop bad B cells.

Nossal GJ.

Nature. 1994 Sep 29;371(6496):375-6. No abstract available.

PMID:
8090215
43.

Tribute to Rodney P. Shearman scientific obstetrics, past and future.

Nossal GJ.

Aust N Z J Obstet Gynaecol. 1994 Jun;34(3):232-4. No abstract available.

PMID:
7848191
44.

Minimal residual disease as the target for immunotherapy of cancer.

Nossal GJ.

Lancet. 1994 May 14;343(8907):1172-4. No abstract available.

PMID:
7909862
45.

A form of immunologic tolerance through impairment of germinal center development.

Pulendran B, Karvelas M, Nossal GJ.

Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2639-43.

46.

Differentiation of the secondary B-lymphocyte repertoire: the germinal center reaction.

Nossal GJ.

Immunol Rev. 1994 Feb;137:173-83. Review. No abstract available.

PMID:
8034334
47.

Negative selection of lymphocytes.

Nossal GJ.

Cell. 1994 Jan 28;76(2):229-39. Review.

PMID:
8293461
48.

Life, death and the immune system.

Nossal GJ.

Sci Am. 1993 Sep;269(3):52-62. Review. No abstract available.

PMID:
8211091
49.

Tolerance and ways to break it.

Nossal GJ.

Ann N Y Acad Sci. 1993 Aug 12;690:34-41. Review.

PMID:
8368749
50.

A second chance for bad B cells.

Nossal GJ.

Curr Biol. 1993 Jul 1;3(7):460-2. No abstract available.

PMID:
15335716

Supplemental Content

Loading ...
Support Center